Ascenta Therapeutics

Ascenta Therapeutics, Inc.Ascenta Therapeutics, Inc. specializes in biotechnology solutions that improve healthcare delivery. The company is headquartered in Malvern, US.The company specializes in delivering innovative therapeutic solutions that cater to healthcare industry needs, with a focus on advanced software applications and integrated service platforms. These solutions enhance operational efficiency and address critical challenges faced by healthcare providers, such as patient data management and treatment optimization. The primary customer base includes medium to large healthcare enterprises, utilizing these products to streamline processes and improve service delivery.Ascenta Therapeutics generates revenue through a structured transaction model, primarily based on subscription services and direct sales of its software solutions. Clients engage with the firm through annual subscription agreements providing access to core offerings, including updates and customer support. The company also engages in B2B partnerships, integrating products into larger platforms serving the healthcare industry.Ascenta Therapeutics plans to develop and launch new therapeutic products aimed at enhancing treatment efficacy, with specific releases expected in the upcoming year. The company is also targeting expansion into new markets, specifically focusing on South America and Southeast Asia by late 2023.8 mn from February 2010 will be utilized to support these initiatives, ensuring that their new product offerings and market expansion strategies are adequately financed.

1. Series C

   Apr 9, 2007

   Amount

   $50M

   Investors

   Locked

2. Series B

   Mar 14, 2007

   Amount

   $30M

   Investors

   Locked

3. Series A

   Dec 5, 2003

   Amount

   $5.5M

   Investors

   Locked